Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalEtoposideBreast NeoplasmsNeoplasm StagingSurvival AnalysisPrognosisDrug Administration ScheduleSurvival RateLung NeoplasmsMethotrexateCarboplatinPaclitaxelVinblastineInduction ChemotherapyNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmNeoplasmsTime FactorsBleomycinAntimetabolites, AntineoplasticDeoxycytidineOrganoplatinum CompoundsFollow-Up StudiesCytarabineAntineoplastic Agents, AlkylatingAnthracyclinesSalvage TherapyChemotherapy, Cancer, Regional PerfusionCarcinoma, Non-Small-Cell LungOvarian NeoplasmsNeoplasm MetastasisNeutropeniaVomitingTesticular NeoplasmsTransplantation, AutologousNauseaAdenocarcinomaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicProspective StudiesHodgkin DiseaseRadiotherapy, AdjuvantRadiotherapyColorectal NeoplasmsAntibiotics, AntineoplasticClinical Trials as TopicDacarbazineNeoplasms, Germ Cell and EmbryonalGranulocyte Colony-Stimulating FactorCarmustineKaplan-Meier EstimateCamptothecinRecurrenceBrain NeoplasmsLomustineDose-Response Relationship, DrugLeukopeniaBone NeoplasmsInfusions, IntravenousPlatinum CompoundsMelphalanDisease ProgressionOsteosarcomaDrug TherapyInfusions, Intra-ArterialAntiemeticsThiotepaMitomycinLiver NeoplasmsTumor Markers, BiologicalHematopoietic Stem Cell TransplantationMitoxantronePeritoneal NeoplasmsPalliative CareLymphatic MetastasisStomach NeoplasmsTegafurRadiotherapy DosageAntibodies, Monoclonal, HumanizedDaunorubicinCell Line, TumorGerminomaCarcinoma, Squamous CellCarcinomaPrecursor Cell Lymphoblastic Leukemia-LymphomaRandomized Controlled Trials as TopicLeukemia, Myeloid, AcuteLymphomaAntibodies, Monoclonal